These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Intraoperative anaphylactic/anaphylactoid reaction to infusion of a modified liquid gelatin]. Israelian LA; Lubnin AIu Anesteziol Reanimatol; 2004; (2):36-40. PubMed ID: 15206275 [TBL] [Abstract][Full Text] [Related]
23. [Histamine H1 and H2 receptor blockade as a supplementary premedication principle in elective surgery]. Schöning B; Lorenz W; Doenicke A Schweiz Rundsch Med Prax; 1985 Mar; 74(13):315-22. PubMed ID: 2859648 [No Abstract] [Full Text] [Related]
24. Practical therapy of shock. Rocmans P; Quadu B Med Welt; 1975 Aug; 26(33-34):1477-8. PubMed ID: 1177719 [No Abstract] [Full Text] [Related]
25. [Hemoglobin solution as an oxygen transporter. Study of physico-chemical and pharmacological properties]. Labrude P; Vigneron C; Streiff F Agressologie; 1976; 17(1):49-57. PubMed ID: 962028 [No Abstract] [Full Text] [Related]
26. [Physico-chemical characteristics of various plasma substitutes]. Granath K; Strömberg R Minerva Anestesiol; 1968 Nov; 34(11):1300-11. PubMed ID: 5715827 [No Abstract] [Full Text] [Related]
27. [Indications for plasma substitutes]. Tschirren B; Hess FA Schweiz Med Wochenschr; 1975 Jun; 105(24):771-4. PubMed ID: 1145160 [TBL] [Abstract][Full Text] [Related]
28. [On the possibility of using a plasma substitute]. Tognetti A Acta Anaesthesiol; 1966; 17():Suppl 1:61-71. PubMed ID: 6014342 [No Abstract] [Full Text] [Related]
29. [Anaphylactic reaction to volume substitute agents]. Kleinhans D; Vitzthum AG Dtsch Med Wochenschr; 1989 Jan; 114(1):37. PubMed ID: 2910698 [No Abstract] [Full Text] [Related]
30. [Infusion therapy with dextrans. Clinical results of a multicentric study]. Gregori M Beitr Infusionther Klin Ernahr; 1981; 8():98-9. PubMed ID: 6172115 [No Abstract] [Full Text] [Related]
31. Do plasma substitutes have additional properties beyond correcting volume deficits?: Shock 25:2103-116, 2006. Wiedermann CJ Shock; 2007 Mar; 27(3):339-42. PubMed ID: 17304118 [No Abstract] [Full Text] [Related]
32. [Evaluation and indications of the therapeutic use of the blood and its substitutes in oligovolemia]. Rudowski W Pol Tyg Lek; 1965 Dec; 20(52):1993-7. PubMed ID: 5862733 [No Abstract] [Full Text] [Related]
33. Hemodilution, oxygen consumption, and recovery from surgical shock. --A study on the efficacy of different plasma substitutes. Dawidson I Ann Clin Res; 1981; 13 Suppl 33():44-7. PubMed ID: 7342843 [TBL] [Abstract][Full Text] [Related]
34. [Management of shock with drugs and volume replacement with special reference to blood component therapy]. Nydegger U Schweiz Rundsch Med Prax; 1986 Jul; 75(29):886-92. PubMed ID: 3738336 [No Abstract] [Full Text] [Related]
36. [Anaphylactoid reaction in a child after plasma transfusion]. Diakin VM; Ovcharenko VV Vestn Khir Im I I Grek; 1974 Oct; 113(10):127-8. PubMed ID: 4215195 [No Abstract] [Full Text] [Related]
37. [Plasma and plasma substitutes in the therapy of shock]. Heisto H Tidsskr Nor Laegeforen; 1966 May; 86(9):729-32. PubMed ID: 5916272 [No Abstract] [Full Text] [Related]
38. Rapid restoration of microcirculatory blood flow with hyperviscous and hyperoncotic solutions lowers the transfusion trigger in resuscitation from hemorrhagic shock. Wettstein R; Erni D; Intaglietta M; Tsai AG Shock; 2006 Jun; 25(6):641-6. PubMed ID: 16721273 [TBL] [Abstract][Full Text] [Related]